Can Hashimoto thyroiditis be a sequela of anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hashimoto Thyroiditis Cannot Be a Sequela of Anemia

No, Hashimoto thyroiditis cannot be a sequela of anemia—the relationship is reversed: Hashimoto thyroiditis and other autoimmune thyroid diseases can cause or coexist with anemia, not the other way around.

Understanding the Directional Relationship

Hashimoto Thyroiditis as a Cause of Anemia

Hashimoto thyroiditis is an autoimmune disease that can lead to anemia through multiple mechanisms, not a consequence of anemia. The pathophysiologic relationship flows from thyroid dysfunction to hematologic abnormalities 1.

  • Autoimmune thyroid disease (AITD) itself, independent of thyroid hormone status, can affect hemoglobin levels through shared autoimmune pathways 1.

  • Patients with type 1 diabetes are prone to autoimmune disorders including Hashimoto thyroiditis and pernicious anemia as separate but related autoimmune conditions 2.

Mechanisms by Which Hashimoto Causes Anemia

Multiple pathways explain how Hashimoto thyroiditis leads to anemia:

  • Pernicious anemia and atrophic gastritis frequently coexist with autoimmune thyroid disease through shared autoimmune mechanisms 1, 3.

  • Autoimmune hemolytic anemia can develop in patients with Hashimoto thyroiditis as part of overlapping autoimmune syndromes 4, 5.

  • Hypothyroidism from Hashimoto disease causes anemia through bone marrow depression, decreased erythropoietin production, and altered iron metabolism 1.

  • Celiac disease and rheumatic disorders associated with AITD contribute to anemia risk 1.

Clinical Evidence of Association

Case Reports Demonstrate Hashimoto Preceding Anemia

Published case series consistently show Hashimoto thyroiditis diagnosed before or concurrent with anemia, never as a consequence:

  • A 20-year-old woman with established Hashimoto thyroiditis subsequently developed autoimmune hemolytic anemia and later Evans' syndrome, demonstrating the progression from thyroid disease to hematologic complications 4.

  • A 49-year-old woman with Hashimoto thyroiditis developed both autoimmune thrombocytopenia and autoimmune hemolytic anemia, requiring plasmapheresis for combined autoimmune diseases 5.

  • A 68-year-old woman with myasthenia gravis had concurrent Hashimoto thyroiditis and pernicious anemia as separate autoimmune conditions sharing immunogenetic pathways 3.

Diagnostic Implications

Thyroid dysfunction and AITD should be considered in differential diagnosis of treatment-resistant or refractory anemia 1.

  • Elevated red blood cell distribution width (RDW) in patients without iron deficiency anemia may require evaluation for Hashimoto thyroiditis, particularly in females 6.

  • RDW is significantly increased in Hashimoto patients compared to controls, even without anemia, reflecting subclinical inflammation 6.

Common Pitfall to Avoid

The critical error is confusing association with causation in the wrong direction. While anemia and thyroid disease frequently coexist, anemia does not cause autoimmune thyroid disease. The shared autoimmune pathogenesis means both conditions may arise from common immunogenetic factors, but Hashimoto thyroiditis is a primary autoimmune disorder, not a secondary consequence of anemia 4, 1.

Iron deficiency anemia can negatively influence thyroid hormone status, but this affects thyroid hormone metabolism, not the development of autoimmune thyroiditis itself 1.

References

Research

Anemia in thyroid diseases.

Polish archives of internal medicine, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Could red cell distribution width be a marker in Hashimoto's thyroiditis?

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2014

Related Questions

Does Hashimoto's thyroiditis increase the risk of developing anemia of chronic disease?
Does a patient with Hashimoto's (Autoimmune Thyroiditis) who develops anemia experience an increase in thyroid antibody levels?
What is the medical interpretation of low WBC, low RBC, high MCV, high MCH, low RDW, positive ANA, high pANCA, high iron, MTHFR C677T, Prothrombin G20210A, and Hashimoto's thyroiditis?
What is the appropriate diagnosis and treatment for a patient with hypertension, iron deficiency anemia, and hypothyroidism?
Can anemia affect thyroid levels in individuals taking Synthroid (levothyroxine)?
What is the most appropriate initial management for a patient with three days of nausea and vomiting, muscle weakness, hypokalemia (serum potassium 2.9 mmol/L) and presumed volume depletion?
What is the recommended levofloxacin (Vantin) dosage for an adult with a urinary tract infection, including adjustments for complicated infection or impaired renal function, contraindications, and alternative oral agents?
In a 2‑month‑old infant (~5 kg) with fecal impaction in the rectal ampulla on computed tomography, leukocytosis (white blood cell count 14,000) and elevated C‑reactive protein (90 mg/L), and with the surgeon deeming surgery unnecessary, what is the recommended next medical management?
What is the appropriate evaluation and management for a 35‑year‑old woman with recurrent uncomplicated urinary tract infections (≥2 episodes in the past 6 months or ≥3 in the past 12 months)?
According to the latest research, what is the recommended amount and type of screen exposure for a healthy toddler aged 12–36 months?
What are the clinical manifestations of mycotoxin exposure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.